Winston Pharmaceuticals, Inc.
WPHM
$0.00
$0.000.00%
OTC PK
| 03/31/2010 | 12/31/2009 | 09/30/2009 | 06/30/2009 | 03/31/2009 | |
|---|---|---|---|---|---|
| Net Income | -2.34M | -2.66M | -3.36M | -3.77M | -4.59M |
| Total Depreciation and Amortization | 8.80K | 9.00K | 9.30K | 9.60K | 9.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 131.60K | 94.20K | 55.80K | 26.70K | -- |
| Change in Net Operating Assets | -1.35M | -1.65M | -9.60K | 520.80K | 1.23M |
| Cash from Operations | -3.54M | -4.20M | -3.30M | -3.21M | -3.35M |
| Capital Expenditure | 0.00 | -700.00 | -700.00 | -700.00 | -15.30K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -1.00K | 900.00 | 0.00 | 0.00 | -1.70K |
| Cash from Investing | -1.00K | 200.00 | -700.00 | -700.00 | -17.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 51.50K | 134.50K | 127.50K | 127.50K | 83.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 4.00M | 4.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 0.00 | 227.10K | 227.10K |
| Cash from Financing | 51.50K | 134.50K | 127.50K | 4.35M | 4.31M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -3.49M | -4.06M | -3.18M | 1.14M | 942.70K |